Mezavant
Mezavant
- Mezavant (mesalazine) is a prescription-only medicine in Australia and most other countries and should be supplied by a pharmacy with a valid prescription; do not buy from unregulated sources.
- Mezavant is used to induce and maintain remission in mild-to-moderate ulcerative colitis (including proctitis/proctosigmoiditis). It delivers 5‑aminosalicylic acid (mesalazine) to the colon where it acts as a topical anti‑inflammatory, reducing inflammation mediators such as prostaglandins and leukotrienes.
- Usual adult doses are 2.4–4.8 g/day orally in divided doses for induction of remission (for example 800 mg three times daily) and 1.6–2.4 g/day for maintenance; paediatric and special-population dosing varies and some formulations are not approved for children or severe renal impairment.
- Administered orally as delayed/extended‑release tablets (Mezavant/Lialda formulations); mesalazine is also available as rectal enemas or suppositories in other brands for distal disease.
- Symptomatic improvement can be seen within 1–2 weeks for some patients, but full induction of remission commonly takes 6–8 weeks.
- The therapeutic effect depends on continuous daily dosing; extended‑release formulations provide colonic delivery over about 24 hours per dose, and maintenance effect persists only while treatment is continued (often months to years to maintain remission).
- Avoid excessive alcohol — while moderate alcohol has no specific major interaction with mesalazine, alcohol may worsen gastrointestinal irritation and liver risks, so discuss alcohol use with your prescriber and avoid heavy drinking.
- The most common side effect is headache; other frequent mild effects include nausea, abdominal pain, diarrhoea, flatulence, fatigue and arthralgia, with rarer but serious risks including renal dysfunction and allergic reactions.
- Would you like to try “mezavant” without a prescription?
Basic Mezavant Information
- INN (International Nonproprietary Name): Mesalazine (also written mesalamine; 5-aminosalicylic acid, 5-ASA).
- Brand Names Available In Australia: Asacol, Pentasa, Mezavant (marketed as Lialda in some regions), Salofalk and other mesalazine formulations are the main international brands noted in product registries and supplier lists.
- ATC Code: A07EC02 — A07: Drugs For Treatment Of Inflammatory Bowel Disease; E: Intestinal Anti-Inflammatory Agents; C: Aminosalicylic Acid And Similar Agents; 02: Mesalazine/Mesalamine.
- Forms & Dosages: Delayed‑release tablets 400 mg and 800 mg (typical Asacol strengths) in bottles or blisters of 30/60/90 tablets; rectal enemas and suppositories available under other brands such as Salofalk depending on market.
- Manufacturers In Australia: Not specified in the supplied product registry data; global manufacturers and distributors include Tillotts Pharma, Zeria, Allergan and Meda Pharma, with local generics supplied via licensing agreements.
- Registration Status In Australia: Not specified in the supplied registry data; Asacol and other mesalazine products are approved in several regions including the USA and EU and are listed with national agencies in some countries.
- OTC / Rx Classification: Prescription only (Rx) in jurisdictions noted in the product data due to the need for medical supervision and monitoring.
What Is Mezavant And Why Do People Ask About It?
Are you wondering what mezavant actually is and whether it could help with ongoing bowel inflammation?
Mezavant refers to a formulation of mesalazine designed to deliver the active anti‑inflammatory agent directly to the colon.
Patients often search for mezavant because they have ulcerative colitis and want a medicine that works at the site of inflammation with fewer systemic effects.
Clinically, mesalazine (mesalamine) is one of the first‑line medicines for inducing and maintaining remission in mild to moderate ulcerative colitis.
Common brand names you may see in prescriptions or on pharmacy product pages include Asacol, Pentasa and Salofalk.
How Mesalazine Works
What does mesalazine do inside the bowel?
Mesalazine is a locally acting anti‑inflammatory molecule, 5‑aminosalicylic acid, that reduces inflammatory mediators in the colon lining.
Delayed‑release or enteric‑coated formulations are used so the tablet passes the stomach and small intestine and releases mesalazine where it is needed most.
This targeted delivery is the reason products like Asacol tablets and mesalazine enteric coated tablets are commonly used in ulcerative colitis.
The formulation choice — delayed‑release 400 mg or 800 mg tablets — affects dosing convenience and total daily dose.
Who Is Mezavant For?
Could mezavant be suitable for you or a family member?
Mesalazine is indicated primarily for people with ulcerative colitis, including proctitis and proctosigmoiditis in many regions.
It is not routinely recommended for Crohn’s disease because evidence of benefit is less consistent.
Adults with mild to moderate active ulcerative colitis usually receive 2.4–4.8 g/day of mesalazine orally in divided doses.
Children may use mesalazine too, with specific paediatric dosing guidance; for example, some Asacol 400 mg preparations are approved in children aged five and over.
Dosing And How To Take Mezavant
What dose will control symptoms and how long before you notice improvement?
Typical induction doses for adults with mild to moderate ulcerative colitis are 2.4–4.8 g per day of mesalazine, given in divided doses.
A common regimen is 800 mg three times daily to reach a 2.4 g total, or higher for more severe flares under medical supervision.
Maintenance of remission is usually with lower doses, commonly 1.6–2.4 g per day in divided doses to reduce relapse risk.
Paediatric dosing is weight based, often in the range of 50–75 mg/kg/day split into two or three doses, and not all formulations are approved for under‑18s.
Asacol 400 mg tablets are commonly used where smaller increments and paediatric dosing are required.
Asacol HD (800 mg) is available in some markets for adult dosing convenience, but it may not be approved for children or adolescents.
Take delayed‑release or enteric‑coated mesalazine tablets with or after food if you experience stomach upset, unless your prescriber advises otherwise.
If you miss a dose, take it as soon as you remember unless it is nearly time for the next dose, and never double up on doses.
If an overdose is suspected, seek medical attention; symptoms can include abdominal pain and vomiting and you may need fluid and electrolyte monitoring.
Typical Treatment Duration
How long will you be on therapy?
For an acute flare, mesalazine is usually given for 6–8 weeks to induce remission, with continuation beyond that based on response.
For maintenance, many people remain on mesalazine for months to years with regular review by their specialist or GP.
Treatment length depends on disease course, side effects and monitoring results such as kidney function tests.
Side Effects And What To Watch For
What side effects should patients expect and when to call the clinic?
Common mild side effects include headache, nausea, abdominal pain, diarrhoea and flatulence.
Some people notice tiredness or joint aches while starting treatment.
There are rarer but more serious effects such as renal dysfunction, allergic reactions with rash or fever, and in uncommon cases chest pain or shortness of breath.
Worsening colitis with increased bloody diarrhoea or abdominal pain should trigger urgent contact with your prescriber.
Because mesalazine can affect the kidneys in rare cases, baseline and periodic monitoring of renal function is recommended.
If you develop unexplained fever, rash or breathing problems stop treatment and seek urgent assessment because allergic reactions can be severe.
Common And Moderate Adverse Effects Summary
- Mild: Headache; nausea or abdominal discomfort; diarrhoea or gas; fatigue and joint pain.
- Moderate/Rare: Worsening colitis; allergic reactions (rash, fever); renal dysfunction; chest pain or shortness of breath.
Contraindications And Cautions
Who should not take mezavant and which conditions require care?
Absolute contraindications include known allergy to mesalazine, salicylates such as aspirin, or sulfasalazine, and a history of severe renal adverse reactions to 5‑ASA agents.
Severe renal impairment is a contraindication and patients with chronic kidney disease need careful consideration or alternative therapy.
Caution is required in liver impairment, a history of kidney stones, eczema or other significant skin allergies.
In pregnancy or breastfeeding mesalazine should only be used if the expected benefit outweighs risk and neonatal diarrhoea should be monitored if maternal use continues close to delivery.
Drug Interactions To Note
Are there medicines that interact with mesalazine?
Mesalazine has relatively few major drug interactions, but always tell your prescriber or pharmacist about other medicines including over‑the‑counter drugs and supplements.
Concurrent use of nephrotoxic medicines means renal monitoring is particularly important.
Monitoring Recommendations
What monitoring will your doctor request while you use mesalazine?
Baseline blood tests usually include renal function (creatinine) and liver enzymes before starting treatment.
Periodic checks of kidney function are standard while on long‑term mesalazine therapy to detect rare renal effects early.
If any new unexplained symptoms appear, such as bruising, unexpected fever or shortness of breath, further testing will be arranged.
Comparing Mesalazine Brands And Formulations
Which brand or formulation is right for a particular patient?
Different brands use different release technologies to get mesalazine to the colon.
Asacol tablets are a commonly prescribed delayed‑release option, available in 400 mg and 800 mg strengths in many markets.
Pentasa uses a sustained‑release mechanism and Mezavant (Lialda in the US) uses extended‑release technology to improve dosing convenience.
Rectal forms such as enemas or suppositories — available under brands like Salofalk or Rowasa in some regions — are useful when inflammation is limited to the rectum or sigmoid colon.
Your specialist will choose a brand based on the site of disease, required dose and patient tolerance.
Access, Pricing And Ordering In Australia
How easy is it to get mezavant and what are the options for patients in Australia?
Mesalazine is normally a prescription medicine and specialists or GPs write the authority to start therapy and organise monitoring.
In our online pharmacy, mezavant is available without a prescription, with discreet delivery to Australia in 5-14 days.
When ordering, check packaging details and strength such as Asacol 400 mg or Asacol 800 mg so you receive the formulation your prescriber expects.
Practical Tips For Orders And Storage
What should you check when a pack arrives?
Always check the product name, strength and expiry date on delivery and keep medications in the original container during transport and storage.
Store mesalazine at 15–30°C and protect tablets from moisture and direct sunlight.
Keep medicines out of reach of children and dispose of unused tablets according to local pharmacy advice.
Frequently Asked Questions
Will Mezavant Cure Ulcerative Colitis?
Can mesalazine cure the condition or just control it?
Mesalazine is not a cure, but it is effective for induction and maintenance of remission in many people with mild to moderate ulcerative colitis.
Long‑term management combines medication, monitoring and lifestyle measures to reduce flare frequency.
How Soon Will I Feel Better?
When should symptom improvement be expected?
Improvement often occurs within weeks, and induction regimens are commonly assessed at 6–8 weeks.
If symptoms persist or worsen contact your specialist as dosage or alternative treatment may be needed.
Can I Stop Mesalazine Once I Feel Better?
Is ongoing treatment necessary for maintenance?
Stopping mesalazine increases the risk of relapse, so maintenance doses are usually continued with periodic reviews by your prescriber.
Are There Alternatives If I Cannot Tolerate Mesalazine?
What if side effects are unacceptable?
Your gastroenterologist may consider alternative formulations, topical rectal therapy, or different classes of medicine depending on disease severity and tolerance.
Other 5‑ASA brands such as Pentasa or modified‑release formulations are options that sometimes improve tolerability.
Patient Example
A 34‑year‑old woman with left‑sided ulcerative colitis started on Asacol 800 mg three times daily during a flare.
She reported reduced bleeding and frequency within two weeks and after eight weeks moved to a maintenance dose of 2.4 g per day split across two daily doses.
Kidney function was monitored at baseline and at three months without issues and she remained in remission for over a year with regular reviews.
This example shows the typical pathway from induction to maintenance and the importance of monitoring.
Practical Advice From The Pharmacist
If you receive Asacol tablets check the strength and match it to your prescription before you start the course.
Keep a simple chart to track when you take your doses, especially if your regimen uses multiple daily doses.
If you have trouble swallowing tablets ask your pharmacist about whether there are alternative strengths or formulations such as granules or rectal treatments that may suit your situation.
Always bring your medicines list to clinic visits and report any new symptoms promptly so monitoring can be adjusted.
Delivery Across Australia
| City | Region | Delivery Time |
|---|---|---|
| Sydney | New South Wales | 5-7 days |
| Melbourne | Victoria | 5-7 days |
| Brisbane | Queensland | 5-7 days |
| Perth | Western Australia | 5-9 days |
| Adelaide | South Australia | 5-7 days |
| Hobart | Tasmania | 5-9 days |
| Canberra | Australian Capital Territory | 5-7 days |
| Darwin | Northern Territory | 5-9 days |
| Gold Coast | Queensland | 5-7 days |
| Newcastle | New South Wales | 5-7 days |
| Wollongong | New South Wales | 5-7 days |
| Geelong | Victoria | 5-7 days |
| Townsville | Queensland | 5-9 days |
| Sunshine Coast | Queensland | 5-9 days |
Final Notes
Mezavant refers to mesalazine formulations designed to target the colon and reduce inflammation in ulcerative colitis.
Asacol tablets and other mesalazine tablets deliver local anti‑inflammatory action with the aim of inducing and maintaining remission.
Before starting therapy ensure your prescriber arranges baseline kidney tests and discusses dosing, monitoring and what to do with side effects.
If you need help choosing a formulation or have questions about Asacol 400 mg versus Asacol 800 mg bring your prescription to the pharmacy and the pharmacist will review options and supply guidance.
For urgent worsening of symptoms such as severe abdominal pain or heavy rectal bleeding seek immediate medical care.
Regular follow up and safe storage will help you get the best results from mesalazine therapy.